1.
Clinical Efficacy of Rifampicin Nanoparticle Local Delivery in Post-Surgical Wound Infections Caused by Resistant Bacteria. LMJHCR [Internet]. 2025 Dec. 31 [cited 2026 May 22];3(2):1-11. Available from: https://linkmjhcr.com/index.php/lmj/article/view/138